|Podcasts|January 23, 2018
Episode 1: 2018 Trends
Author(s)Michelle Maskaly, Christen Harm
In this podcast, Pharmaceutical Executive editors, Christen Harm and Michelle Maskaly, discuss the 2018 pharma trends, specifically biosimilars and eEnablement, and takeaways from the 2017 Veeva European Commercial Summit.
Advertisement
In this episode, Pharmaceutical Executive editors discuss the 2018 pharma trends, specifically biosimilars and eEnablement, and takeaways from the 2017 Veeva European Commercial Summit.
The podcast can be downloaded directly from SoundCloud, iTunes, GooglePlay, Stitcher, and Overcast.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5